!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!CALY NEWS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! - 500 Beiträge pro Seite

[aze2]

wer hat welche? ist ja die letzte zeit recht still um caly geworden.

[mfierke]

was soll man zu dieser Aktie schon sagen, bin bei 0,58 eingestiegen, jetzt heißt es aussitzen, wann kommen die Zahlen ??? mfg mh

[chartwaechter]

Unilab, California`s Largest Lab Testing Provider, Begins Offering Calypte`s HIV-1 Urine Tests

ALAMEDA, Calif.--(BW HealthWire)--Jan. 30, 2002--Calypte Biomedical Corporation (OTCBB:CALY - news) announced today that Unilab Corporation, (Nasdaq:ULAB - news), has successfully completed the California licensing requirements to begin offering Calypte`s non-invasive HIV-1 urine antibody tests to clients. Unilab is California`s largest provider of clinical laboratory services and operates over 50 laboratories with primary testing facilities in Los Angeles, San Jose and Sacramento, and more than 400 regional service facilities located throughout the state. Unilab will market Calypte`s urine HIV-1 antibody test to all clients as an alternative screening test for HIV. Testing will be performed at Unilab`s reference laboratory in Los Angeles.

``I am delighted that our HIV-1 urine test is now being offered by Unilab,`` said Nancy Katz, president and CEO of Calypte. ``Unilab is recognized as the premier clinical testing laboratory in California. The availability of Calypte`s HIV-1 urine test for Unilab`s broad client base will greatly facilitate our direct sales and marketing efforts to increase the number of people who become aware of their health status through screening. The Calypte test provides an excellent alternative to blood testing for HIV since a conventional random urine specimen is simple to collect, non-invasive and provides equivalent accuracy to blood when coupled with the urine western blot test,`` she added.

``Unilab is pleased to be California`s first laboratory to offer Calypte`s urine HIV-1 test state-wide,`` said Dr. Michael Hanbury, Unilab senior vice president and chief scientific officer. ``Calypte`s urine HIV-1 screening test and Western Blot confirmatory tests have received clearance for use by the FDA and have demonstrated substantially equivalent performance to serum tests in clinical trials reported in the literature and conducted by Unilab. Urine provides an excellent alternative for sexually transmitted disease screening and can now be used for HIV in conjunction with Unilab`s amplified molecular testing capabilities for chlamydia and gonorrhea for adolescent and male patients, thus furthering access for screening patients at risk for sexually transmitted diseases. The addition of the urine HIV test to Unilab`s testing portfolio will simplify and provide greater access for sexually transmitted disease screening to patients throughout California and Arizona,`` he added.

Through sales and marketing programs, Calypte has generated interest in urine HIV testing among Community Based Organizations and AIDS Service Organizations. These organizations will now have the ability to offer urine HIV screening to their clients. In addition, Calypte and Unilab will work together to develop and implement programs to notify Unilab`s clients and other healthcare providers about the availability of HIV-1 urine antibody testing through Unilab.

Calypte Biomedical Corporation, headquartered in Alameda, Calif., is a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services for Human Immunodeficiency Virus Type 1 (HIV-1), sexually transmitted diseases and other infectious diseases. Calypte`s tests include the screening EIA and supplemental Western Blot tests, the only two FDA-approved HIV-1 antibody tests that can be used on urine samples. The company believes that accurate, non-invasive urine-based testing methods for HIV and other infectious diseases may make important contributions to public health by helping to foster an environment in which testing may be done safely, economically, and painlessly. Calypte markets its products in countries worldwide through international distributors and strategic partners. Current product labeling including specific product performance claims can be found on our website at www.calypte.com.

Wenn einer gut englisch kann, so sollte er das für die Unwissenden den Kern der Mitteilung übersetzen, ob diese Neuigkeit positiv ist.

Danke
Chartwaechter

[Palerm]

Hallo Calypter,
merkt ihr was????
An einem Freitag bringen die wieder gute News heraus. Ja lernen die denn nie etwas????!!!!!
Am Freitag kaufen die Amis nicht gerne und am Montag ist alles eingepreist. Was für eine sch..ß Öffentlichkeitsarbeit.
Na ja vielleicht wird doch noch alles gut.
Palerm, der gehofft hatte, dass der Vorstand von Calypte auch mal dazu lernt.
Ciao

[AkzieX]

@Palerm
Der 30. Januar ist also ein Freitag....
sag mal, merkst du auch noch was????

[Palerm]

ups, caly macht mich noch verrückt.
Nix für ungut :-)
Palerm

[liebemachtblind]

ALARMO PÜERLEMO ANDYLERNOO

CALPYSOOOOOOOOOooooooooooooooooooooooooooo